CGEM

8.74

1.27% 0.11

Dopo l'orario di chiusura: 8.46 -0.28 -3.20%

Cullinan Therapeutics Inc (CGEM)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$8.63

Aprire:

$8.82

Volume 24 ore:

1.63M

Relative Volume:

2.24

Capitalizzazione di mercato:

$516.31M

Reddito:

Utile/perdita netta:

$-153.16M

Rapporto P/E:

-2.3686

EPS:

-3.69

Flusso di cassa netto:

$-134.48M

1 W Prestazione:

+23.97%

1M Prestazione:

+38.95%

6M Prestazione:

+14.85%

1 anno Prestazione:

-50.37%

Intervallo 1D:

$8.53

$9.235

Intervallo di 1 settimana:

$6.845

$9.235

Portata 52W:

$5.68

$17.90

Cullinan Therapeutics Inc Stock (CGEM) Company Profile

Nome

Cullinan Therapeutics Inc

Settore

Healthcare (1140)

Industria

Biotechnology (637)

Telefono

617-410-4650

Indirizzo

ONE MAIN STREET, CAMBRIDGE

Dipendente

111

Cinguettio

Prossima data di guadagno

2024-11-06

Ultimi documenti SEC

CGEM's Discussions on Twitter

Confronta CGEM con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CGEM Cullinan Therapeutics Inc	8.74	457.24M	0	-153.16M	-134.48M	-3.69
VRTX Vertex Pharmaceuticals Inc	408.61	105.69B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	481.07	61.52B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	569.17	60.69B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	837.28	50.05B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	318.02	35.25B	4.56B	-176.77M	225.30M	-1.7177

Cullinan Therapeutics Inc Stock (CGEM) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-08-21	Ripresa	H.C. Wainwright	Buy
2025-06-11	Ripresa	Stifel	Buy
2024-10-24	Iniziato	UBS	Buy
2024-05-01	Iniziato	Stifel	Buy
2024-04-15	Iniziato	William Blair	Outperform
2024-02-15	Iniziato	Wedbush	Outperform
2023-06-15	Iniziato	TD Cowen	Outperform
2022-11-21	Iniziato	BTIG Research	Buy
2021-04-27	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2021-02-02	Iniziato	Evercore ISI	Outperform
2021-02-02	Iniziato	Morgan Stanley	Equal-Weight
2021-02-02	Iniziato	SVB Leerink	Outperform
2021-02-01	Iniziato	H.C. Wainwright	Buy

Mostra tutto

Cullinan Therapeutics Inc Borsa (CGEM) Ultime notizie

05:57 AM

What makes Cullinan Therapeutics Inc. stock attractive to growth fundsMarket Sentiment Report & High Accuracy Swing Entry Alerts - newser.com

05:57 AM

03:45 AM

What momentum shifts mean for Cullinan Therapeutics Inc.2025 Price Momentum & High Accuracy Swing Trade Signals - newser.com

03:45 AM

02:15 AM

Cullinan Therapeutics (NASDAQ:CGEM) Trading Up 11.5% – Here’s Why - Defense World

02:15 AM

Oct 15, 2025

Does Cullinan Therapeutics Inc. qualify in momentum factor screening2025 Key Highlights & Smart Money Movement Alerts - newser.com

Oct 15, 2025

Visual analytics tools that track Cullinan Therapeutics Inc. performance2025 Volatility Report & Weekly Chart Analysis and Guides - newser.com

Oct 15, 2025

Is Cullinan Therapeutics Inc. stock a good choice for value investors2025 Performance Recap & Comprehensive Market Scan Insights - newser.com

Oct 15, 2025

Cullinan Therapeutics Inc. stock prediction for this week2025 EndofYear Setup & Risk Managed Investment Signals - newser.com

Oct 15, 2025

Volume spikes in Cullinan Therapeutics Inc. stock – what they mean2025 Market Sentiment & Daily Profit Focused Screening - newser.com

Oct 15, 2025

Oct 13, 2025

Cullinan Therapeutics Cancer Drug Shows Efficacy In Brain Metastases Among Lung Cancer Patients With Certain Mutations - Sahm

Oct 13, 2025

Oct 12, 2025

Taiho Oncology, Cullinan: Zipalertinib 31.3% Intracranial ORR in NSCLC | CGEM Stock News - Stock Titan

Oct 12, 2025

Oct 11, 2025

Cullinan Therapeutics (NASDAQ:CGEM) Major Shareholder Buys $3,593,698.00 in Stock - MarketBeat

Oct 11, 2025

Lynx1 Capital Management Lp Buys 277,298 Shares of Cullinan Therapeutics (NASDAQ:CGEM) Stock - MarketBeat

Oct 11, 2025

Oct 10, 2025

Lynx1 capital buys Cullinan Therapeutics (CGEM) shares worth $9.8m By Investing.com - Investing.com South Africa

Oct 10, 2025

Lynx1 capital buys Cullinan Therapeutics (CGEM) shares worth $9.8m - Investing.com

Oct 10, 2025

Can machine learning forecast Cullinan Therapeutics Inc. recoveryDay Trade & Daily Profit Focused Screening - newser.com

Oct 10, 2025

How to forecast Cullinan Therapeutics Inc. trends using time series2025 Trade Ideas & Real-Time Chart Breakout Alerts - newser.com

Oct 10, 2025

Cullinan Therapeutics Inc. stock momentum explainedEarnings Performance Report & Weekly Momentum Stock Picks - newser.com

Oct 10, 2025

Here's Why We're Watching Cullinan Therapeutics' (NASDAQ:CGEM) Cash Burn Situation - Sahm

Oct 10, 2025

Oct 09, 2025

Cullinan Therapeutics (NASDAQ:CGEM) Receives Sell (E+) Rating from Weiss Ratings - MarketBeat

Oct 09, 2025

Oct 06, 2025

Reversal indicators forming on Cullinan Therapeutics Inc. stock2025 Volatility Report & Verified Entry Point Signals - newser.com

Oct 06, 2025

Sep 29, 2025

Published on: 2025-09-29 10:05:02 - newser.com

Sep 29, 2025

Cullinan Therapeutics Inc Stock Analysis and ForecastSupport Level Holds & Free Stock Education Platform for New Investors - earlytimes.in

Sep 29, 2025

Sep 28, 2025

What analysts say about Cullinan Therapeutics Inc stockCandlestick Pattern Analysis & Small Budget Wealth Building - earlytimes.in

Sep 28, 2025

How to use a screener to detect Cullinan Therapeutics Inc. breakoutsQuarterly Market Review & Capital Efficiency Focused Strategies - newser.com

Sep 28, 2025

Sep 26, 2025

How moving averages guide Cullinan Therapeutics Inc. tradingMarket Performance Report & High Accuracy Investment Signals - newser.com

Sep 26, 2025

Published on: 2025-09-26 16:18:03 - newser.com

Sep 26, 2025

Sep 25, 2025

Multi asset correlation models including Cullinan Therapeutics Inc.July 2025 Highlights & Daily Stock Trend Watchlist - newser.com

Sep 25, 2025

Sep 24, 2025